BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim K, Lee SA, Park D. Emerging Roles of Ephexins in Physiology and Disease. Cells 2019;8:E87. [PMID: 30682817 DOI: 10.3390/cells8020087] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ding X, Chen Y, Guo C, Fu Y, Qin C, Zhu Q, Wang J, Zhang R, Tian H, Feng R, Liu H, Liang D, Wang G, Teng J, Li J, Tang B, Wang X. Mutations in ARHGEF15 cause autosomal dominant hereditary cerebral small vessel disease and osteoporotic fracture. Acta Neuropathol 2023. [PMID: 36929019 DOI: 10.1007/s00401-023-02560-6] [Reference Citation Analysis]
2 Eckenstaler R, Hauke M, Benndorf RA. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology. Biochemical Pharmacology 2022;206:115321. [DOI: 10.1016/j.bcp.2022.115321] [Reference Citation Analysis]
3 Zhang M, Lin L, Wang C, Zhu J. Double inhibition and activation mechanisms of Ephexin family RhoGEFs. Proc Natl Acad Sci U S A 2021;118:e2024465118. [PMID: 33597305 DOI: 10.1073/pnas.2024465118] [Reference Citation Analysis]
4 Stiffel VM, Thomas A, Rundle CH, Sheng MH, Lau KW. The EphA4 Signaling is Anti-catabolic in Synoviocytes but Pro-anabolic in Articular Chondrocytes. Calcif Tissue Int 2020;107:576-92. [PMID: 32816052 DOI: 10.1007/s00223-020-00747-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yu B, Xu L, Chen L, Wang Y, Jiang H, Wang Y, Yan Y, Luo S, Zhai Z. FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells. Cell Death Dis 2020;11:652. [PMID: 32811808 DOI: 10.1038/s41419-020-02830-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]